BAC BV - The Affinity Experts
BAC discovers, develops and manufactures affinity ligands and affinity purification products serving the growing market of biopharmaceutical research and production. BAC’s CaptureSelect purification and affinity separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. These products enable a reduced time to market, increased purity and yield and an overall lower cost of goods for biopharmaceutical drug development.
BAC’s extensive pipeline of affinity ligands and lead products ensures that there is a purification solution for all major biopharmaceuticals, including biosimilars and vaccines. For more information please download our company presentation or contact us via info@bac.nl
CaptureSelect® products
 |
 |
 |
||
| Custom designed CaptureSelect® ligands |
CaptureSelect® products for Bioprocess |
CaptureSelect® products for Research |
||
|
Platform technology for development of affinity purification products for manufacturing of antibodies and antibody fragments, therapeutic proteins, vaccines and viruses. |
|
BAC’s CaptureSelect technology for use in large scale manufacturing of biopharmaceuticals and Leakage ELISA's supporting our existing product range. |
|
Productline for bench-scale purification and serum depletion. Includes: Antibody Toolbox®, Proteomics Toolbox® and Protein Purification Products. |
BAC News and Events
GE Healthcare and BAC collaborate to launch new bioprocess affinity resin More >
BAC BV and Life Technologies launch high speed affinity HPLC columns for real-time pharmaceutical process monitoring More >
BAC and GE Healthcare expand product offering with the addition of VIISelect Bioprocess media More >
BAC BV collaborates in providing custom CaptureSelect® affinity ligands for Bristol-Myers Squibb’s Adnectin™ biotherapeutics More >